ATLCAR.CD30.CCR4
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ATLCAR.CD30.CCR4, covering 2025-10-20 to 2025-10-20. Get the full timeline:
Most recent: Clinical Trial Update: ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells [Phase 1, Phase 2]